These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31461776)

  • 21. Expandable metal biliary stenting in patients with recurrent premature polyethylene stent occlusion.
    Menon K; Romagnuolo J; Barkun AN
    Am J Gastroenterol; 2001 May; 96(5):1435-40. PubMed ID: 11374679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical advantages of a metal stent with an S-shaped anti-reflux valve in malignant biliary obstruction.
    Lee KJ; Chung MJ; Park JY; Lee DH; Jung S; Bang BW; Park SW; Chung JB; Song SY; Bang S
    Dig Endosc; 2013 May; 25(3):308-12. PubMed ID: 23369050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic adenocarcinoma in a randomized controlled trial.
    Gardner TB; Spangler CC; Byanova KL; Ripple GH; Rockacy MJ; Levenick JM; Smith KD; Colacchio TA; Barth RJ; Zaki BI; Tsapakos MJ; Gordon SR
    Gastrointest Endosc; 2016 Sep; 84(3):460-6. PubMed ID: 26972022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New antireflux self-expandable metal stent for malignant lower biliary obstruction: in vitro and in vivo preliminary study.
    Kim DU; Kwon CI; Kang DH; Ko KH; Hong SP
    Dig Endosc; 2013 Jan; 25(1):60-6. PubMed ID: 23286258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An audit of metal stent palliation for malignant biliary obstruction.
    McDougall NI; Edmunds SE
    J Gastroenterol Hepatol; 2001 Sep; 16(9):1051-4. PubMed ID: 11595072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.
    Stone GW; Ellis SG; Cannon L; Mann JT; Greenberg JD; Spriggs D; O'Shaughnessy CD; DeMaio S; Hall P; Popma JJ; Koglin J; Russell ME;
    JAMA; 2005 Sep; 294(10):1215-23. PubMed ID: 16160130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revascularization in Daily Practice).
    Smits PC; Vlachojannis GJ; McFadden EP; Royaards KJ; Wassing J; Joesoef KS; van Mieghem C; van de Ent M
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1157-1165. PubMed ID: 26210806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction.
    Davids PH; Groen AK; Rauws EA; Tytgat GN; Huibregtse K
    Lancet; 1992 Dec 19-26; 340(8834-8835):1488-92. PubMed ID: 1281903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of metallic stent for unresectable distal malignant biliary obstruction in elderly patients.
    Sakai Y; Iwai T; Shimura K; Gon K; Koizumi K; Ijima M; Chiba K; Nakatani S; Sugiyama H; Tsuyuguchi T; Kamisawa T; Maetani I; Kida M
    World J Gastroenterol; 2018 Jan; 24(1):69-75. PubMed ID: 29358883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cost-effectiveness trial of self-expandable metal stents and plastic biliary stents in malignant biliary obstruction].
    Daróczi T; Bor R; Fábián A; Szabó E; Farkas K; Bálint A; Czakó L; Rutka M; Szűcs M; Milassin Á; Molnár T; Szepes Z
    Orv Hetil; 2016 Feb; 157(7):268-74. PubMed ID: 26853728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reintervention for occluded metal stent in malignant bile duct obstruction: A prospective randomized trial comparing covered and uncovered metal stent.
    Lee BS; Ryu JK; Jang DK; Chung KH; Yoon WJ; Kim J; Woo SM; Lee SH; Lee WJ; Kim YT
    J Gastroenterol Hepatol; 2016 Nov; 31(11):1901-1907. PubMed ID: 27029890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Porcine feasibility and safety study of a new paclitaxel-eluting biliary stent with a Pluronic-containing membrane.
    Jang SI; Kim JH; Kim M; Yang S; Jo EA; Lee JW; Na K; Kim JM; Jeong S; Lee DH; Lee DK
    Endoscopy; 2012 Sep; 44(9):825-31. PubMed ID: 22752887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety and efficacy of percutaneous intraductal radiofrequency ablation in unresectable malignant biliary obstruction: A single-institution experience.
    Cui W; Fan W; Lu M; Zhang Y; Yao W; Li J; Wang Y
    BMC Cancer; 2017 Apr; 17(1):288. PubMed ID: 28438130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of the Za self-expandable metal stent for palliation of malignant biliary obstruction.
    Varadarajulu S; Tutuian R; Gostout C; Kozarek R; Wilcox CM; Cotton PB
    J Clin Gastroenterol; 2004 Jan; 38(1):77-80. PubMed ID: 14679332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plastic or expandable biliary endoprostheses?
    Huibregtse K
    Scand J Gastroenterol Suppl; 1993; 200():3-7. PubMed ID: 8016568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial).
    Nikolsky E; Kosinski E; Mishkel GJ; Kimmelstiel C; McGarry TF; Mehran R; Leon MB; Russell ME; Ellis SG; Stone GW
    Am J Cardiol; 2005 Mar; 95(6):709-15. PubMed ID: 15757595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preliminary report on a new hybrid metal stent for EUS-guided biliary drainage (with videos).
    Song TJ; Lee SS; Park DH; Seo DW; Lee SK; Kim MH
    Gastrointest Endosc; 2014 Oct; 80(4):707-711. PubMed ID: 25053527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation.
    Herdeg C; Göhring-Frischholz K; Haase KK; Geisler T; Zürn C; Hartmann U; Wöhrle J; Nusser T; Dippon J; May AE; Gawaz M
    Circ Cardiovasc Interv; 2009 Aug; 2(4):294-301. PubMed ID: 20031731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.